Nexpram (Escitalopram)

Escitalopram blocks the serotonin transporter (SERT) on presynaptic neurons, preventing reabsorption of serotonin. This raises serotonin levels in the synaptic cleft, enhancing serotonergic signaling, which is associated with improved mood and reduced anxiety.

The specific dose of Nexpram is determined by the prescribing clinician based on the individual’s condition, age, response, and tolerability. Patients should follow the dosage instructions provided by their healthcare provider and not adjust the dose on their own.

Safety of escitalopram in pregnancy and lactation has not been definitively established. Healthcare providers weigh potential benefits against possible risks to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss treatment options with their doctor.

To request Nexpram, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Escitalopram is often compared with other SSRIs such as sertraline or fluoxetine. It is generally considered to have a favorable side‑effect profile and strong efficacy for both depression and anxiety. Choice of therapy depends on individual response, tolerability, drug interactions, and clinician judgment.

Nexpram should be stored at ambient temperature, below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

Nexpram is taken orally, usually once daily with or without food, as directed by the prescribing clinician. The tablet should be swallowed whole with water and not crushed or chewed unless specifically instructed.

Serious risks include the potential for serotonin syndrome, especially when combined with other serotonergic drugs, and the emergence of suicidal thoughts or behaviors, particularly in younger adults during early treatment. Prompt medical attention is required if these symptoms occur.

Nexpram is contraindicated in patients who have a known hypersensitivity to escitalopram or any SSRI, those currently taking monoamine oxidase inhibitors, or individuals with a history of severe serotonin syndrome. Clinicians should assess each patient’s medical history before prescribing.